September 14-15, 2020
Vienna, Austria
PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in your field. Listen to motivating keynotes from thought leaders, or rub elbows with pioneers across the globe. Madrid is all set for an amazing event as PULSUS proudly presents the “3rd International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases” slated on September 14-15, 2020 at Vienna, Austria. The theme of the conference is “Leading Advancements and Remedies in the Neurodegenerative Disorders”.
Neurology focusses on the diagnosis and treatment of diseases affecting the nervous system. The nervous system includes brain and Spinal cord. Neurodegenerative Disorders occurs when the neurons in the human brain are affected. Neurodegeneration is the process of loss of structure or function of neurons, it may also include death of neurons. Neurodegeneration leads to many diseases like Myotrophic lateral sclerosis, Huntington's , Parkinson's and Alzheimer's. The most common type are Parkinson's disease and Alzheimer's disease.
Pulsus Group
Pulsus Group is a Medical publisher that adheres to stringent peer-review procedure with a view to set an example in promoting standard medical research with integrity. Pulsus Group takes pride in getting the endorsements of prestigious associations and societies like Germany medical societies. As an ardent supporter of medical publishing, Pulsus Group closely associates with the Germany and other international medical research associations. It publishes a wide range of medical journals that focus on medical specialties like Neurology, Cardiology, Pscyhiatry, Surgery, Dental Health, Physics and Reproductive Medicine.
Pulsus Group is an internationally renowned peer-review publisher in scientific, technical, and medical journals established in the year 1984 with offices in Ontario, Canada and Hyderabad. India has acquired Andrew John Publishing and openaccessjournals.com to expand its Open Access Publishing through its 50+ journals in association with 20+ International medical and scientific societies.
Pulsus through its pulsusconference.com is been very instrumental to provide an invaluable channel for scientists and researchers to exchange ideas and research by creating a forum for discussing the possibilities of future collaborations between universities, institutions, research bodies and organizations from different countries through international CME/CPD accredited conferences and meetings.
Why to attend?
Alzheimers 2020 is an ideal opportunity to create awareness about the leading advancements in the therapies for the cure of Alzheimer's, Dementia and many other neurodegenerative diseases and the direction of future developments. This Conference will be an exciting opportunity to share academic and clinical developments and research and to build on social interactions and support each other.
The main aim of our conference is to gather individuals from Neurology and to share their ideas and inventions for the well being of mankind.
Benefits
Who should attend?
Target Audience
Session 1: Dementia
Dementia is a common term to describe memory loss leading to hindrance in daily routines. It is specifically not a single disease, it describes many symptoms associated with the brain's working capacity. Alzheimer's is the most common type of Dementia. Vascular dementia which is the second most common type is caused after stroke in brain cells. People with dementia faces many difficulties in communicating with others, memorizing things, ability to focus and pay attention, judgment and reasoning, visual perception.
Related Societies and Associations:
Dementia Society of America, Alzheimer's Association, Alzheimer's Society United Against Dementia, Dementia UK, Alzheimer Society Canada, Alzheimer Society Ontario, Alzheimer's & Related Disorders Society of India, Cognitive Neuroscience Society.
Session 2: Alzheimer and Parkinson
Alzheimer's Disease (AD) affects the proper memory power, thinking ability and brings behavioral change in a human being. AD is not a normal part of aging, it gets worse with increasing age. Currently, no proper medicine is available to cure AD, researchers are working on it to find out medications for proper cure. Parkinson Disease (PD) affects the predominately dopamine producing neurons in particular area of brain known as substantia nigra. It causes tremors in body, slowness of movements, rigidity of limb, gait and balance problems. Some societies provides assisted living facilities for patients with AD and PD. The patients can’t take decisions on their own, so they assign someone for all legal works which includes creating power of attorney also.
Related Societies and Associations:
Alzheimer Europe, Alzheimer Society Toronto, Parkinson's Foundation, Parkinson's Disease And Movement Disorder Society, Neurodegenerative Disease Society of Toronto - NDST, Dementia Action Alliance, The Alzheimer's Society of Ireland, Neuroscience Society.
Session 3: Epilepsy
Epilepsy is a neurological disorder in which the nerve cells activities is disrupted leading to seizures. The ability to interpret feelings slows down which is known as aura. The person becomes apathic in nature. After a seizure takes place, it leaves the body in postictal state. The brain’s electrical activity is recorded by Electroencephalogram to do the monitoring and to find out the affected part. Anticonvulsants and proper diet are given to minimize the effects of epilepsy. All over world, approximately 50 million people are dealing with epilepsy.
Related Societies and Associations:
Pilgrims' Friendly Society, The Dementia Society Ottawa and Renfrew Country, Alzheimer Society of Calgary, Parkinson's UK, Epilepsy Foundation, Parkinson Canada, American Epilepsy Society, International Behavioural Neuroscience Society.
Session 4: Multiple Sclerosis
An uncertain disease of Central Nervous System (CNS) in which the protecting covers of nerve cells of spinal cord and brain are deteriorated. Many investigators thinks MS to be a autoimmune disorder in which the immune system of body launches a defensive mechanism for its safety. There is no specific cure for Multiple Sclerosis (MS), many patients do well with therapies, because medications have may side effects. A patient with MS faces difficulties in communicating with others. New research are being done to work with stem cells for treatment of MS. Genetics play a major role in getting affected by MS, Vitamin D plays a role in treatment but still its proper use is not specified, to stop the spread of MS we need to find treatment for repairing of myelin sheath.
Related Societies and Associations:
The ALS Association, Alzheimer's Research UK (ARUK), Fisher Center for Alzheimer's Research Foundation, Neurological Society of India, World Federation of Neurology, European Federation of Neurological Associations, British Neuroscience Association, Society of Neuroscience.
Session 5: Migraine
Migraine headache results from any physiological changes in brain resulting in nausea and vomiting. Pain is very intense and unbearable after some extent which may get worse after physical extortion. Usually it affects only one side of brain but in few cases it affects bilaterally. In some cases, people experiences warning symptoms or an aura which ranges from flashing lights, loud music and blind spots. Factors which trigger migraine are hormonal imbalances, oral contraceptive pills, certain food products, stress, oversleeping, etc. Diclofenac is a easily available medicine for relief of migraine pain. Proper diet and exercise should be maintained to get relief.
Related Societies and Associations:
Dementia Society of America, Alzheimer's Association, Alzheimer's Society United Against Dementia, Dementia UK, Alzheimer Society Canada, Alzheimer Society Ontario, Alzheimer's & Related Disorders Society of India, Cognitive Neuroscience Society.
Session 6: Prion Disease
Transmissible spongiform encephalopathies (TSEs), generally known as prion diseases are a cluster of degenerative brain disorders defined by tiny holes giving a spongy appearance to the brain. Prions are infectious agents composed entirely of proteins. This can be diagnosed when brain tissue is diagnosed under microscope. Very rare disorder, which affects one in every one million people every year. TSEs progress rate is very high which usually results in death. Proper treatment is not available till now, research is being going on to find out cure for TSEs.
Related Societies and Associations:
Alzheimer Europe, Alzheimer Society Toronto, Parkinson's Foundation, Parkinson's Disease And Movement Disorder Society, Neurodegenerative Disease Society of Toronto - NDST, Dementia Action Alliance, The Alzheimer's Society of Ireland, Neuroscience Society.
Session 7: Motor Neurone Diseases
Motor Neurone Diseases are a collection of conditions which cause the nerves in brain and spine to stop its function. They are rare but fatal and incurable form of neurodegeneration. It can decrease the life expectancy of an individual. Motor neuron diseases affect either upper motor neurons (UMN) or lower motor neurons (LMN). It is a more likely to be a genetic disorder but doesn’t runs in many generations. Physiotherapy and speech and language therapist can help in living healthy life. Only few drugs are available to slightly slow down the progress of this condition, no proper treatment is available. The patients becomes emotionally very weak, so proper care and love should be shown. Few people who are dealing with ALS which is a type of Motor Neurone Disease are Stephen Hawking and Jason Becker have been living for several years.
Related Societies and Associations:
Pilgrims' Friendly Society, The Dementia Society Ottawa and Renfrew Country, Alzheimer Society of Calgary, Parkinson's UK, Epilepsy Foundation, Parkinson Canada, American Epilepsy Society, International Behavioural Neuroscience Society.
Session 8: Huntingtons Disease
It is a progressive type of dementia which is caused by mutation in gene for protein called huntingtin. It affects the central part of the brain resulting in defects in movement, moods and thinking skills. There is no cure which can block or reverse the course of Huntingtons Disease. Every child of parent with HD gene has 50/50 chance of inheriting the gene causing disease. If the child have not inherited gene, he or she will never show any symptom and it will not pass on to their next generation. Antipsychotic drugs are there for temporary relief but it comes up with side effects like cholera, nausea, fatigue, etc. HD causes disability which worsens with time. People with this gene mutation usually dies within 15-20 years after getting diagnosed.
Related Societies and Associations:
The ALS Association, Alzheimer's Research UK (ARUK), Fisher Center for Alzheimer's Research Foundation, Neurological Society of India, World Federation of Neurology, European Federation of Neurological Associations, British Neuroscience Association, Society of Neuroscience.
Session 9: Spinocerebellar Ataxia
Spinocerebellar ataxia (SCA) is gradually developing degeneration of nerves, which is a genetic disease having numerous other types. Also known as Sprinocerebellar atrophy or spinocerebellar degeneration. There is no proper cure or treatment, so, sometimes it becomes fatal. It can affect person of any age group generally 1 or 2 in 1 million people worldwide. This condition is inherited in autosomal dominant nature, which states that only one copy of altered gene is enough to cause the disorder. Only rehabilitation can help patients to deal with SCA.
Related Societies and Associations:
Dementia Society of America, Alzheimer's Association, Alzheimer's Society United Against Dementia, Dementia UK, Alzheimer Society Canada, Alzheimer Society Ontario, Alzheimer's & Related Disorders Society of India, Cognitive Neuroscience Society.
Session 10: Spinal Muscular Atrophy
Spinal Muscular Atrophy is a hereditary disease which cause weakness and wastage in the voluntary muscles of legs and arms of infants and children. This disorder is caused by an abnormal or missing gene known as survival motor neuron gene. There are 3 types of SMA; Type 1 is evident at birth or in first few weeks, Type 2 normally begins in 6 to 18 months and Type 3 usually shows in between 2 and 17 years of age. There is no cure of SMA, treatment mainly consists of management of symptoms and prevention of complications. Researchers have started doing work in the field of strategies to cope up with SMA. The US FDA have approved nusinersen (brand name Spinzara) to carry out treatment of SMA on Dec. 23, 2016.
Related Societies and Associations:
Alzheimer Europe, Alzheimer Society Toronto, Parkinson's Foundation, Parkinson's Disease And Movement Disorder Society, Neurodegenerative Disease Society of Toronto - NDST, Dementia Action Alliance, The Alzheimer's Society of Ireland, Neuroscience Society.
Session 11: Demyelinating Diseases
It is a condition in which the myelin sheath of nerve fibres of brain, optic nerves and spinal cord are damaged. When myelin sheath gets deteriorated, nerve impulses slows down or often stops working causing many neurological problems. Demyelination tends to be patchy or segmental, affecting multiple areas simultaneously. Remyelination often takes place with complete recovery and regeneration of nerve cells. Demyelination is caused by viral infections, metabolic issues, oxygen loss and physical compression. Symptoms include numbness, loss of reflex actions, blurred vision, memory loss, fatigue, etc. There are vaccines to help decrease chances of demyelination. They are not curable but taking with your doctor helps in better understanding of the problem.
Related Societies and Associations:
Pilgrims' Friendly Society, The Dementia Society Ottawa and Renfrew Country, Alzheimer Society of Calgary, Parkinson's UK, Epilepsy Foundation, Parkinson Canada, American Epilepsy Society, International Behavioural Neuroscience Society.
Session 12: Cerebral Palsy
Cerebral Palsy is a group of neurological disorders which appears in infants or early childhood causing permanent affect in body movements, muscle coordination and balance. Early signs usually appears before 3 years of age, if not visible in infant stage. Symptoms includes reflex actions, seizures, hearing loss and impaired or blurred vision. It is not a progressive disease, which means it doesn’t worsens with time. It is not totally curable but with proper care, a child’s capabilities can be checked. Treatment may include therapies, surgery to correct anatomical abnormalities. CP occurs in about 2.1 per 1000 live births. With proper care and treatment, children with CP can live normally like others.
Related Societies and Associations:
The ALS Association, Alzheimer's Research UK (ARUK), Fisher Center for Alzheimer's Research Foundation, Neurological Society of India, World Federation of Neurology, European Federation of Neurological Associations, British Neuroscience Association, Society of Neuroscience.
Session 13: Cognitive Impairment
Mild cognitive impairment causes mild but noticeable changes in decrease of cognitive abilities like thinking abilities and memory power. It is an intermediate stage between cognitive decline of normal aging and the severe signs of dementia. In amnestic MCI, person starts to forget important information's like appointments, conversations, etc. Whereas in nonamnestic MCI, person’s thinking ablility is hampered. There is no cause for MCI, but studies shows that shrinkage of hippocampus, enlargement of brain’s fluid-filled spaces and reduced use of glucose may be possible causes. Risk factors for MCI- increasing age, lifestyle problems and a presence of a specific form of gene APOE-e4, though presence of this gene doesn’t assure that an individual can get MCI. The prevalence of MCI varies by age group. 6.7% for ages 60–64; 8.4% for ages 65–69, 10.1% for ages 70–74, 14.8% for ages 75–79, and 25.2% for ages 80–84. No medications are there to treat MCI properly.
Related Societies and Associations:
Dementia Society of America, Alzheimer's Association, Alzheimer's Society United Against Dementia, Dementia UK, Alzheimer Society Canada, Alzheimer Society Ontario, Alzheimer's & Related Disorders Society of India, Cognitive Neuroscience Society.
Session 14: Stroke
Brain attack or stroke takes place when circulation of blood in brain is interrupted or the blood vessels bursts and squirts out blood. The brain cells die due to reduced oxygen flow and functioning of brain stops. Stroke has no defined symptoms, all will take place suddenly and after affects will be there. The treatment stages are prevention, therapy after the brain attack and post stroke rehabilitation. Most popular class of drug to treat strokes are antithrombotics (antiplatelet agents and anticoagulants) and thrombolytics. The most disability which takes place after stroke is one-sided paralysis. Clinical trails have been done by Worldwide Scientists to know about stroke. Many organizations help patients with stroke to live life to the fullest.
Related Societies and Associations:
Alzheimer Europe, Alzheimer Society Toronto, Parkinson's Foundation, Parkinson's Disease And Movement Disorder Society, Neurodegenerative Disease Society of Toronto - NDST, Dementia Action Alliance, The Alzheimer's Society of Ireland, Neuroscience Society.
Session 15: Convulsion
Convulsion is a state in which the whole body muscle contracts and relaxes very quickly resulting in uncontrolled shaking of body. Convulsion is also used as a term for seizures. This takes place due to some sort of electrical activity mishap in brain. Also it can be caused by chemicals in blood or some infections like meningitis. Symptoms usually last from few seconds to around 20 minutes.
Related Societies and Associations:
Pilgrims' Friendly Society, The Dementia Society Ottawa and Renfrew Country, Alzheimer Society of Calgary, Parkinson's UK, Epilepsy Foundation, Parkinson Canada, American Epilepsy Society, International Behavioural Neuroscience Society.
Session 16: Neurodegeneration
Neurodegeneration is a progressive loss of neuron’s structure and function leading towards an irreversible damage and death of neurons. It is final stage for aging and a pathway for neurodenegerative diseases. It encircles a wide range of clinical diseases like Alzheimer’s Disease, Parkinson’s Disease and many other neurological disorders. Degenerative diseases may be life threatening or non-curable. Treatments and therapies may improve symptoms, relieve pains and will also help in increasing mobility. These problems gets diagnosed by ECG and some specific nerve tests.
Related Societies and Associations:
The ALS Association, Alzheimer's Research UK (ARUK), Fisher Center for Alzheimer's Research Foundation, Neurological Society of India, World Federation of Neurology, European Federation of Neurological Associations, British Neuroscience Association, Society of Neuroscience.
Session 17: Neurorehabilitation
Neurorehabilitation is a treatment of nerves affected by neurodegenerative disorders specially designed and supervised by doctors. It often improves function, reduces symptoms which affects the overall condition of patients to some extent. Many experts from different fields have to come together as a team to make it a success like neurosurgeon, orthopedic surgeon therapist, counselor, social workers, psychiatrist. It takes into account diseases such as Dementia, Alzheimer’s, Parkinson’s, etc. This treatment promotes the highest level of independence possible for them. It also helps in rebuilding self-esteem and a positive attitude towards the life which results in getting adapted to new situations. It gives a ray of hope to the patients. All over the world, there are many cases of patients who have got relief from many serious neurological diseases by this neurorehabilitation technique.
Related Societies and Associations:
Dementia Society of America, Alzheimer's Association, Alzheimer's Society United Against Dementia, Dementia UK, Alzheimer Society Canada, Alzheimer Society Ontario, Alzheimer's & Related Disorders Society of India, Cognitive Neuroscience Society.
Session 18: Neurology
Neurology is a special branch of medical sciences which deals primarily with disorders in the nervous system. It involves diagnosing and treating conditions related to the central, peripheral and autonomic nervous system. The person who deals with this branch is called as Neurologist. In this branch, the root cause of problem is identified and then proper therapies and treatments are provided to get rid if the problem. Neuroscience describes the scientific study of the mechanics of the central nervous system such as its function, genetics and physiology, structure as well as its application to understand diseases of the nervous system.
Related Societies and Associations:
Alzheimer Europe, Alzheimer Society Toronto, Parkinson's Foundation, Parkinson's Disease And Movement Disorder Society, Neurodegenerative Disease Society of Toronto - NDST, Dementia Action Alliance, The Alzheimer's Society of Ireland, Neuroscience Society.
Session 19: Neuropathy
Neuropathy refers to a condition in which the whole nervous system is affected. It may lead to some neurodegenerative diseases. It’s symptoms include numbness or tingling, to pricking sensations in legs or arms, muscle weakness. Neuropathy affecting just one nerve is known as mononeuropathy whereas if its effect is shown in many nerve cells then it is called as symmetrical polyneuropathy or simply neuropathy. It is caused by genetic diseases, endocrine and metabolic diseases, inflammatory disease, etc. Many medications have been found which eases the neuropathic pain.
Related Societies and Associations:
Pilgrims' Friendly Society, The Dementia Society Ottawa and Renfrew Country, Alzheimer Society of Calgary, Parkinson's UK, Epilepsy Foundation, Parkinson Canada, American Epilepsy Society, International Behavioural Neuroscience Society.